Guidelines for the control of glycopeptide-resistant enterococci in hospitals

被引:34
作者
Cookson, BD
Macrae, MB
Barrett, SP
Brown, DFJ
Chadwick, C
French, GL
Hateley, P
Hosein, IK
Wade, JJ
机构
[1] Hlth Protect Agcy, Specialist & Reference Microbiol Div, Lab Healthcare Associated Infect, London, England
[2] UCL, NHS Trust, Dept Clin Microbiol, London, England
[3] Charing Cross Hosp, Dept Med Microbiol, London, England
[4] Addenbrookes Hosp, Clin Microbiol & Publ Hlth Lab, Cambridge, England
[5] Christie Hosp NHS Trust, Manchester M20 4BX, Lancs, England
[6] St Thomas Hosp, Kings & St Thomas Sch Med, Dept Infect, London, England
[7] St Bartholomews Hosp, Pathol & Patient Serv, London, England
[8] Cardiff & Vale NHS Trust, Dept Infect Prevent & Control, Cardiff, Wales
[9] Kings Coll Hosp London, Hlth Protect Agcy London, London, England
关键词
glycopeptide-resistant enterococci; GRE; hospital infection; infection control; guidelines;
D O I
10.1016/j.jhin.2005.02.016
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The increase since the mid 1980s in glycopepetide resistant enterococci (GRE) raised concerns about the limited options for antimicrobial therapy, the implications for ever-increasing numbers of immunocompromised hospitalised patients, and fuelled fears, now realised, for the transfer of gtycopeptide resistance to more pathogenic bacteria, such as Staphylococcus aureus. These issues underlined the need for guidelines for the emergence and control of GRE in the hospital setting. This Hospital Infection Society (HIS) and Infection Control Nurses Association (ICNA) working party report reviews the literature relating to GRE prevention and control. It provides guidance on microbiological. investigation, treatment and management, including antimicrobial prescribing and infection control. measures. Evidence identified to support recommendations has been categorized. A risk assessment approach is recommended and areas for research and development identified. (c) 2005 The Hospital Infection Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:6 / 21
页数:16
相关论文
共 135 条
[1]   Effect of abolishment of the use of antimicrobial agents for growth promotion on occurrence of antimicrobial resistance in fecal enterococci from food animals in Denmark [J].
Aarestrup, FM ;
Seyfarth, AM ;
Emborg, HD ;
Pedersen, K ;
Hendriksen, RS ;
Bager, F .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (07) :2054-2059
[2]   BSAC standardized disc susceptibility testing method [J].
Andrews, JM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 :43-57
[3]  
[Anonymous], 1995, INFECT CONT HOSP EP, V16, P105
[4]  
[Anonymous], 2002, MMWR MORB MORTAL WKL, V51, P902
[5]  
[Anonymous], 2002, MMWR MORB MORTAL WKL, V51, P565
[6]  
[Anonymous], 2001, SYSTEMATIC REV HLTH, DOI DOI 10.1002/9780470693926
[7]   Vancomycin-resistant enterococci in intensive-care hospital settings: Transmission dynamics, persistence, and the impact of infection control programs [J].
Austin, DJ ;
Bonten, MJM ;
Weinstein, RA ;
Slaughter, S ;
Anderson, RM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (12) :6908-6913
[8]  
Ayliffe G.A.J., 1992, CONTROL HOSP INFECT
[9]  
Ayliffe GAJ, 1998, J HOSP INFECT, V39, P253, DOI 10.1016/S0195-6701(98)90293-6
[10]   THE STRUCTURE AND MODE OF ACTION OF GLYCOPEPTIDE ANTIBIOTICS OF THE VANCOMYCIN GROUP [J].
BARNA, JCJ ;
WILLIAMS, DH .
ANNUAL REVIEW OF MICROBIOLOGY, 1984, 38 :339-357